세계의 벤더 중립 아카이브(VNA) 및 의료영상저장전송시스템(PACS) 시장 동향 분석, 경쟁 구도 및 예측(2019-2031년) : 유형, 컴포넌트, 전개 모드, 용도, 최종사용자, 지역별

Global Vendor Neutral Archive (VNA) and PACS Market to Reach USD 6.3 Billion by 2031

Global Vendor Neutral Archive (VNA) and PACS Market is flourishing because of the growing adoption of digital imaging and electronic health records (EHR) in healthcare facilities and a spurring demand for cloud-based VNA solutions.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Vendor Neutral Archive (VNA) and PACS Market size at USD 4.3 billion in 2024. During the forecast period between 2025 and 2031, BlueWeave expects Global Vendor Neutral Archive (VNA) and PACS Market size to expand at a CAGR of 5.90% reaching a value of USD 6.3 billion by 2031. Advances in imaging equipment, rising healthcare investment, and the rise in medical procedures due to the prevalence of chronic diseases are major growth factors for Global Vendor Neutral Archive (VNA) and PACS Market. Additionally, the growing adoption of technologies, such as cloud storage and AI-driven analytics, is expected to drive the market over the forecast period.

Opportunity - Increasing Demand for Digital Health and Medical Imaging

The rising adoption of digital health technologies, such as telehealth, and growing demand for medical imaging are emerging as key growth drivers for Global Vendor Neutral Archive (VNA) and PACS Market. With the rising adoption of digitization in the healthcare industry, the need for efficient storage, retrieval, and sharing of medical images and patient data has spiked. The advancements in imaging technologies (like MRI, CT scans, and digital X-rays) have resulted in a rise in the volume of patient data that needs to be managed. VNAs enable healthcare providers to store data in a vendor-neutral format, ensuring long-term accessibility and interoperability across systems.

Impact of Escalating Geopolitical Tensions on Global Vendor Neutral Archive (VNA) and PACS Market

Intensifying geopolitical tensions posed many challenges for Global Vendor Neutral Archive (VNA) and PACS Market. The manufacturing and distribution processes of VNA and PACS systems are hampered by geopolitical instability causing disruptions in the global supply chain. Sanctions or tariffs, for example, prevent the free movement of vital software or components related to VNA and PACS. The adoption or deployment of VNA/PACS systems across the healthcare industry may be slowed down by delays experienced by businesses operating in affected areas, which might raise production and delivery costs. The rise in cyberattacks that target essential infrastructure, particularly healthcare systems, is another significant issue linked to geopolitical tensions on Global Vendor Neutral Archive (VNA) and PACS Market.

VNA Segment Dominates Global VNA and PACS Market

The vendor neutral archive (VNA) segment holds the largest share of Global Vendor Neutral Archive (VNA) and PACS Market. A National Center for Biotechnology Information paper claims that the use of vendor-neutral archives (VNA) reduces storage unit costs by over 30% in terms of volume and service and maintenance costs by 10%-15%. VNAs offer centralized patient-imaging records, which enhances the general quality of care in healthcare facilities and propels the market's expansion.

North America Holds Major Share in Global VNA and PACS Market

North America dominates Global Vendor Neutral Archive (VNA) and PACS Market. The region's growing use of cloud storage and the volume of medical imaging data drive the need for a complete system, such VNA/PACS systems, to store, manage, and offer real-time access to medical images in a standardized format and interface. However, over the forecast period, the APAC area is anticipated to expand at a rapid pace. The regional market's expansion is mostly due to the thriving healthcare system, especially in developing nations like South Korea, Vietnam, and India.

Competitive Landscape

Major companies in Global Vendor Neutral Archive (VNA) and PACS Market include Agfa Healthcare, Dell Technologies, Fujifilm, GE Healthcare, IBM, Koninklijke Philips, Lexmark, McKesson, Novarad, Siemens Healthineers, Merge Healthcare, and Nuance Communications. The presence of high number of companies intensify the market competition as they compete to gain a significant market share. These companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches to further enhance their market share.

The in-depth analysis of the report provides information about growth potential and upcoming trends in Global Vendor Neutral Archive (VNA) and PACS Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Vendor Neutral Archive (VNA) and PACS Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Vendor Neutral Archive (VNA) and PACS Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Increasing Adoption of Digital Imaging and Electronic Health Records (EHR) in Healthcare Facilities
    • 3.2.1.2. Growth in the Demand for Cloud-Based VNA Solutions
    • 3.2.1.3. Rising Need for Interoperability and Consolidation of Medical Imaging Data
  • 3.2.2. Restraints
    • 3.2.2.1. High Initial Investment and Implementation Costs
    • 3.2.2.2. Data Security and Privacy Concerns in Storing Medical Imaging Data
    • 3.2.2.3. Complexity in Integrating VNA with Legacy Healthcare Systems
  • 3.2.3. Opportunities
    • 3.2.3.1. Expansion of Healthcare Services in Emerging Markets
    • 3.2.3.2. Increasing Demand for Scalable, Flexible Storage Solutions
  • 3.2.4. Challenges
    • 3.2.4.1. Ensuring Data Integrity and Seamless Access to Historical Imaging Data
    • 3.2.4.2. Competition from Traditional PACS Solutions and Proprietary Storage Systems
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Vendor Neutral Archive (VNA) and PACS Market: Marketing Strategies

5. Global Vendor Neutral Archive (VNA) and PACS Market: Pricing Analysis

6. Global Vendor Neutral Archive (VNA) and PACS Market: Geographical Analysis

• 6.1. Global Vendor Neutral Archive (VNA) and PACS Market, Geographical Analysis, 2024
• 6.2. Global Vendor Neutral Archive (VNA) and PACS Market, Market Attractiveness Analysis, 2024-2031

7. Global Vendor Neutral Archive (VNA) and PACS Market Overview

• 7.1. Market Size & Forecast, 2019-2031
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
    • 7.2.1.1. Vendor Neutral Archive (VNA)
    • 7.2.1.2. Picture Archiving and Communication System (PACS)
  • 7.2.2. By Component
    • 7.2.2.1. Software
    • 7.2.2.2. Hardware
    • 7.2.2.3. Services
  • 7.2.3. By Deployment Mode
    • 7.2.3.1. Cloud
    • 7.2.3.2. On-premises
    • 7.2.3.3. Hybrid
  • 7.2.4. By Application
    • 7.2.4.1. Radiology
    • 7.2.4.2. Cardiology
    • 7.2.4.3. Oncology
    • 7.2.4.4. Orthopedics
    • 7.2.4.5. Others
  • 7.2.5. By End User
    • 7.2.5.1. Hospitals
    • 7.2.5.2. Diagnostic Centers
    • 7.2.5.3. Research Institutes
    • 7.2.5.4. Others
  • 7.2.6. By Region
    • 7.2.6.1. North America
    • 7.2.6.2. Europe
    • 7.2.6.3. Asia Pacific (APAC)
    • 7.2.6.4. Latin America (LATAM)
    • 7.2.6.5. Middle East and Africa (MEA)

8. North America Vendor Neutral Archive (VNA) and PACS Market

• 8.1. Market Size & Forecast, 2019-2031
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Component
  • 8.2.3. By Deployment Mode
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
    • 8.2.6.1. United States
    • 8.2.6.1.1. By Type
    • 8.2.6.1.2. By Component
    • 8.2.6.1.3. By Deployment Mode
    • 8.2.6.1.4. By Application
    • 8.2.6.1.5. By End User
    • 8.2.6.2. Canada
    • 8.2.6.2.1. By Type
    • 8.2.6.2.2. By Component
    • 8.2.6.2.3. By Deployment Mode
    • 8.2.6.2.4. By Application
    • 8.2.6.2.5. By End User

9. Europe Vendor Neutral Archive (VNA) and PACS Market

• 9.1. Market Size & Forecast, 2019-2031
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Component
  • 9.2.3. By Deployment Mode
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
    • 9.2.6.1. Germany
    • 9.2.6.1.1. By Type
    • 9.2.6.1.2. By Component
    • 9.2.6.1.3. By Deployment Mode
    • 9.2.6.1.4. By Application
    • 9.2.6.1.5. By End User
    • 9.2.6.2. United Kingdom
    • 9.2.6.2.1. By Type
    • 9.2.6.2.2. By Component
    • 9.2.6.2.3. By Deployment Mode
    • 9.2.6.2.4. By Application
    • 9.2.6.2.5. By End User
    • 9.2.6.3. Italy
    • 9.2.6.3.1. By Type
    • 9.2.6.3.2. By Component
    • 9.2.6.3.3. By Deployment Mode
    • 9.2.6.3.4. By Application
    • 9.2.6.3.5. By End User
    • 9.2.6.4. France
    • 9.2.6.4.1. By Type
    • 9.2.6.4.2. By Component
    • 9.2.6.4.3. By Deployment Mode
    • 9.2.6.4.4. By Application
    • 9.2.6.4.5. By End User
    • 9.2.6.5. Spain
    • 9.2.6.5.1. By Type
    • 9.2.6.5.2. By Component
    • 9.2.6.5.3. By Deployment Mode
    • 9.2.6.5.4. By Application
    • 9.2.6.5.5. By End User
    • 9.2.6.6. Belgium
    • 9.2.6.6.1. By Type
    • 9.2.6.6.2. By Component
    • 9.2.6.6.3. By Deployment Mode
    • 9.2.6.6.4. By Application
    • 9.2.6.6.5. By End User
    • 9.2.6.7. Russia
    • 9.2.6.7.1. By Type
    • 9.2.6.7.2. By Component
    • 9.2.6.7.3. By Deployment Mode
    • 9.2.6.7.4. By Application
    • 9.2.6.7.5. By End User
    • 9.2.6.8. The Netherlands
    • 9.2.6.8.1. By Type
    • 9.2.6.8.2. By Component
    • 9.2.6.8.3. By Deployment Mode
    • 9.2.6.8.4. By Application
    • 9.2.6.8.5. By End User
    • 9.2.6.9. Rest of Europe
    • 9.2.6.9.1. By Type
    • 9.2.6.9.2. By Component
    • 9.2.6.9.3. By Deployment Mode
    • 9.2.6.9.4. By Application
    • 9.2.6.9.5. By End User

10. Asia Pacific Vendor Neutral Archive (VNA) and PACS Market

• 10.1. Market Size & Forecast, 2019-2031
  • 10.1.1. By Value (USD Billion)
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Component
  • 10.2.3. By Deployment Mode
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
    • 10.2.6.1. China
    • 10.2.6.1.1. By Type
    • 10.2.6.1.2. By Component
    • 10.2.6.1.3. By Deployment Mode
    • 10.2.6.1.4. By Application
    • 10.2.6.1.5. By End User
    • 10.2.6.2. India
    • 10.2.6.2.1. By Type
    • 10.2.6.2.2. By Component
    • 10.2.6.2.3. By Deployment Mode
    • 10.2.6.2.4. By Application
    • 10.2.6.2.5. By End User
    • 10.2.6.3. Japan
    • 10.2.6.3.1. By Type
    • 10.2.6.3.2. By Component
    • 10.2.6.3.3. By Deployment Mode
    • 10.2.6.3.4. By Application
    • 10.2.6.3.5. By End User
    • 10.2.6.4. South Korea
    • 10.2.6.4.1. By Type
    • 10.2.6.4.2. By Component
    • 10.2.6.4.3. By Deployment Mode
    • 10.2.6.4.4. By Application
    • 10.2.6.4.5. By End User
    • 10.2.6.5. Australia & New Zealand
    • 10.2.6.5.1. By Type
    • 10.2.6.5.2. By Component
    • 10.2.6.5.3. By Deployment Mode
    • 10.2.6.5.4. By Application
    • 10.2.6.5.5. By End User
    • 10.2.6.6. Indonesia
    • 10.2.6.6.1. By Type
    • 10.2.6.6.2. By Component
    • 10.2.6.6.3. By Deployment Mode
    • 10.2.6.6.4. By Application
    • 10.2.6.6.5. By End User
    • 10.2.6.7. Malaysia
    • 10.2.6.7.1. By Type
    • 10.2.6.7.2. By Component
    • 10.2.6.7.3. By Deployment Mode
    • 10.2.6.7.4. By Application
    • 10.2.6.7.5. By End User
    • 10.2.6.8. Singapore
    • 10.2.6.8.1. By Type
    • 10.2.6.8.2. By Component
    • 10.2.6.8.3. By Deployment Mode
    • 10.2.6.8.4. By Application
    • 10.2.6.8.5. By End User
    • 10.2.6.9. Vietnam
    • 10.2.6.9.1. By Type
    • 10.2.6.9.2. By Component
    • 10.2.6.9.3. By Deployment Mode
    • 10.2.6.9.4. By Application
    • 10.2.6.9.5. By End User
    • 10.2.6.10. Rest of APAC
    • 10.2.6.10.1. By Type
    • 10.2.6.10.2. By Component
    • 10.2.6.10.3. By Deployment Mode
    • 10.2.6.10.4. By Application
    • 10.2.6.10.5. By End User

11. Latin America Vendor Neutral Archive (VNA) and PACS Market

• 11.1. Market Size & Forecast, 2019-2031
  • 11.1.1. By Value (USD Billion)
• 11.2. Market Share & Forecast
  • 11.2.1. By Type
  • 11.2.2. By Component
  • 11.2.3. By Deployment Mode
  • 11.2.4. By Application
  • 11.2.5. By End User
  • 11.2.6. By Country
    • 11.2.6.1. Brazil
    • 11.2.6.1.1. By Type
    • 11.2.6.1.2. By Component
    • 11.2.6.1.3. By Deployment Mode
    • 11.2.6.1.4. By Application
    • 11.2.6.1.5. By End User
    • 11.2.6.2. Mexico
    • 11.2.6.2.1. By Type
    • 11.2.6.2.2. By Component
    • 11.2.6.2.3. By Deployment Mode
    • 11.2.6.2.4. By Application
    • 11.2.6.2.5. By End User
    • 11.2.6.3. Argentina
    • 11.2.6.3.1. By Type
    • 11.2.6.3.2. By Component
    • 11.2.6.3.3. By Deployment Mode
    • 11.2.6.3.4. By Application
    • 11.2.6.3.5. By End User
    • 11.2.6.4. Peru
    • 11.2.6.4.1. By Type
    • 11.2.6.4.2. By Component
    • 11.2.6.4.3. By Deployment Mode
    • 11.2.6.4.4. By Application
    • 11.2.6.4.5. By End User
    • 11.2.6.5. Rest of LATAM
    • 11.2.6.5.1. By Type
    • 11.2.6.5.2. By Component
    • 11.2.6.5.3. By Deployment Mode
    • 11.2.6.5.4. By Application
    • 11.2.6.5.5. By End User

12. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Market

• 12.1. Market Size & Forecast, 2019-2031
  • 12.1.1. By Value (USD Billion)
• 12.2. Market Share & Forecast
  • 12.2.1. By Type
  • 12.2.2. By Component
  • 12.2.3. By Deployment Mode
  • 12.2.4. By Application
  • 12.2.5. By End User
  • 12.2.6. By Country
    • 12.2.6.1. Saudi Arabia
    • 12.2.6.1.1. By Type
    • 12.2.6.1.2. By Component
    • 12.2.6.1.3. By Deployment Mode
    • 12.2.6.1.4. By Application
    • 12.2.6.1.5. By End User
    • 12.2.6.2. UAE
    • 12.2.6.2.1. By Type
    • 12.2.6.2.2. By Component
    • 12.2.6.2.3. By Deployment Mode
    • 12.2.6.2.4. By Application
    • 12.2.6.2.5. By End User
    • 12.2.6.3. Qatar
    • 12.2.6.3.1. By Type
    • 12.2.6.3.2. By Component
    • 12.2.6.3.3. By Deployment Mode
    • 12.2.6.3.4. By Application
    • 12.2.6.3.5. By End User
    • 12.2.6.4. Kuwait
    • 12.2.6.4.1. By Type
    • 12.2.6.4.2. By Component
    • 12.2.6.4.3. By Deployment Mode
    • 12.2.6.4.4. By Application
    • 12.2.6.4.5. By End User
    • 12.2.6.5. South Africa
    • 12.2.6.5.1. By Type
    • 12.2.6.5.2. By Component
    • 12.2.6.5.3. By Deployment Mode
    • 12.2.6.5.4. By Application
    • 12.2.6.5.5. By End User
    • 12.2.6.6. Nigeria
    • 12.2.6.6.1. By Type
    • 12.2.6.6.2. By Component
    • 12.2.6.6.3. By Deployment Mode
    • 12.2.6.6.4. By Application
    • 12.2.6.6.5. By End User
    • 12.2.6.7. Algeria
    • 12.2.6.7.1. By Type
    • 12.2.6.7.2. By Component
    • 12.2.6.7.3. By Deployment Mode
    • 12.2.6.7.4. By Application
    • 12.2.6.7.5. By End User
    • 12.2.6.8. Rest of MEA
    • 12.2.6.8.1. By Type
    • 12.2.6.8.2. By Component
    • 12.2.6.8.3. By Deployment Mode
    • 12.2.6.8.4. By Application
    • 12.2.6.8.5. By End User

13. Competitive Landscape

• 13.1. List of Key Players and Their Offerings
• 13.2. Global Vendor Neutral Archive (VNA) and PACS Company Market Share Analysis, 2024
• 13.3. Competitive Benchmarking, By Operating Parameters
• 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

14. Impact of Escalating Geopolitical Tensions on Global Vendor Neutral Archive (VNA) and PACS Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

• 15.1. Agfa Healthcare
• 15.2. Dell Technologies
• 15.3. Fujifilm
• 15.4. GE Healthcare
• 15.5. IBM
• 15.6. Koninklijke Philips
• 15.7. Lexmark
• 15.8. McKesson
• 15.9. Novarad
• 15.10. Siemens Healthineers
• 15.11. Merge Healthcare
• 15.12. Nuance Communications
• 15.13. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

• 17.1. Qualitative Research
  • 17.1.1. Primary & Secondary Research
• 17.2. Quantitative Research
• 17.3. Market Breakdown & Data Triangulation
  • 17.3.1. Secondary Research
  • 17.3.2. Primary Research
• 17.4. Breakdown of Primary Research Respondents, By Region
• 17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable